We Must Send a Message to Stanford: Support CCSVI Trial
Posted: Thu Jan 28, 2010 6:05 pm
The CCSVI trial at Stanford faces obstacles which may slow or even prevent it from launching. The problems have been discussed many times here, such as the neurology profession's resistance towards the CCSVI theory. This would be a tragedy, since Stanford is the only medical center that has any experience in the US so far with treatment.
It is time to make your voice heard on this critical frontline. Please write a message to the decision makers at Stanford, they need to know how important this is. Grant applications are due Feb 9th at NMSS, so we have little time.
Below you will find contact names, addresses and emails. Wonderful if you can do paper letters as well as emails. Send this to all your contacts so they can write too!
Here are some suggested points, but write whatever you feel is most important, or what you are most familiar with.
*Urge the Stanford School of Medicine to pursue research into venous obstruction, and the possible causal relationship to multiple sclerosis.
*Explain why this is important to you personally.
*Commend Stanford and Dr. Michael Dake, for being the first medical center in the US to treat venous obstruction in MS patients.
*Stanford is the logical leader for the next phase of research, since they have the experience.
*The National MS Society is standing ready to fund CCSVI research.
*University medical centers in the US Stony Brook, Georgetown University, Duke, Stanford and Univ. South Carolina are readying trial proposals.
*A report on the prevalence of venous obstruction in MS will arrive in February when Buffalo Jacobs Neurological Institute the first part of their blinded study on the correlation of CCSVI and MS.
*Any plans you have for donations to Stanford's CCSVI research.
*In a blinded, peer-reviewed study, Dr. Zamboni found a 100% correlation between Chronic Cerebrospinal Vascular Insufficiency (CCSVI) and MS. J Vasc Surg. 2009 Dec;50(6) http://www.ncbi.nlm.nih.gov/pubmed/19958985
*Correcting this condition using angioplasty or venous stents, Zamboni’s team saw favorable neurological outcomes in MS patients; a halt to relapses and progression, and in many cases (not all) lessened symptoms and restored function.
*The Italian Multiple Sclerosis Foundation has announced it will allocate up to $4.5 million to fund ongoing research into CCSVI.
*The Canadian MS Society is funding research centers as well, Univ. British Columbia, and McMaster/Hamilton.
*The International uni0n of Phlebology has officially classified CCSVI as a congenital vascular malformation, outlining official guidelines for diagnosis and treatment.
Emails:
Here are email addresses ready to copy/paste. You can see who the emails belong to in the address list.
philip.pizzo@stanford.edu; hennessy@stanford.edu; etch@stanford.edu; aarvin@stanford.edu; harry.greenberg@stanford.edu; paul.costello@stanford.edu; jrabin@stanford.edu; manishma@stanford.edu; mddake@stanford.edu
Addresses:
Philip Pizzo, MD
Dean of the School of Medicine
Alway Building, Room M-121,
300 Pasteur Drive
Stanford University
Stanford, California 94305
philip.pizzo@stanford.edu
Dr. Michael Dake
Chief of Interventional Radiology
Stanford University School Of Medicine
Falk Cardiovascular Research Center, 2nd Floor
300 Pastuer Drive
Stanford, California 94305
mddake@stanford.edu
Dr. John L. Hennessy
Office of the President
Building 10
Stanford University
Stanford, CA 94305-2061
hennessy@stanford.edu
Dr. John Etchemendy
Office of the Provost
Building 10
Stanford University
Stanford, CA 94305-2061
etch@stanford.edu
Martha H. Marsh
President and CEO
Stanford Hospital and Clinics
300 Pasteur Drive
Room H3200 Stanford, CA 94305
Ann Margaret Arvin
Vice Provost and Dean of Research
Building 10, Main Quad
Stanford, California 94305-2061
aarvin@stanford.edu
Harry B Greenberg
Senior Associate Dean for Research
Dean's Office, School of Medicine
Alway Bldg., M121
300 Pasteur Dr.
Stanford, California 94305-5119
harry.greenberg@stanford.edu
Paul Costello
Executive Director, Communication and Public Affairs
School of Medicine
555 Middlefield Road Bldg. 110
Menlo Park, California 94025
paul.costello@stanford.edu
Jonathan Rabinovitz
News Editor, editor of Medical Center Report
555 Middlefield Road
Menlo Park, CA 94025
jrabin@stanford.edu
Rosanne Spector
Stanford Medicine Editor
555 Middlefield Road
Menlo Park, CA 94025
Stanford Medicine Editor
manishma@stanford.edu
If you are going to discuss your donation plans, add
Laurel Price Jones
Associate Vice President for Medical Development and Alumni Affairs
2700 Sand Hill Road
Menlo Park, California 94025
lpj@stanford.edu
It is time to make your voice heard on this critical frontline. Please write a message to the decision makers at Stanford, they need to know how important this is. Grant applications are due Feb 9th at NMSS, so we have little time.
Below you will find contact names, addresses and emails. Wonderful if you can do paper letters as well as emails. Send this to all your contacts so they can write too!
Here are some suggested points, but write whatever you feel is most important, or what you are most familiar with.
*Urge the Stanford School of Medicine to pursue research into venous obstruction, and the possible causal relationship to multiple sclerosis.
*Explain why this is important to you personally.
*Commend Stanford and Dr. Michael Dake, for being the first medical center in the US to treat venous obstruction in MS patients.
*Stanford is the logical leader for the next phase of research, since they have the experience.
*The National MS Society is standing ready to fund CCSVI research.
*University medical centers in the US Stony Brook, Georgetown University, Duke, Stanford and Univ. South Carolina are readying trial proposals.
*A report on the prevalence of venous obstruction in MS will arrive in February when Buffalo Jacobs Neurological Institute the first part of their blinded study on the correlation of CCSVI and MS.
*Any plans you have for donations to Stanford's CCSVI research.
*In a blinded, peer-reviewed study, Dr. Zamboni found a 100% correlation between Chronic Cerebrospinal Vascular Insufficiency (CCSVI) and MS. J Vasc Surg. 2009 Dec;50(6) http://www.ncbi.nlm.nih.gov/pubmed/19958985
*Correcting this condition using angioplasty or venous stents, Zamboni’s team saw favorable neurological outcomes in MS patients; a halt to relapses and progression, and in many cases (not all) lessened symptoms and restored function.
*The Italian Multiple Sclerosis Foundation has announced it will allocate up to $4.5 million to fund ongoing research into CCSVI.
*The Canadian MS Society is funding research centers as well, Univ. British Columbia, and McMaster/Hamilton.
*The International uni0n of Phlebology has officially classified CCSVI as a congenital vascular malformation, outlining official guidelines for diagnosis and treatment.
Emails:
Here are email addresses ready to copy/paste. You can see who the emails belong to in the address list.
philip.pizzo@stanford.edu; hennessy@stanford.edu; etch@stanford.edu; aarvin@stanford.edu; harry.greenberg@stanford.edu; paul.costello@stanford.edu; jrabin@stanford.edu; manishma@stanford.edu; mddake@stanford.edu
Addresses:
Philip Pizzo, MD
Dean of the School of Medicine
Alway Building, Room M-121,
300 Pasteur Drive
Stanford University
Stanford, California 94305
philip.pizzo@stanford.edu
Dr. Michael Dake
Chief of Interventional Radiology
Stanford University School Of Medicine
Falk Cardiovascular Research Center, 2nd Floor
300 Pastuer Drive
Stanford, California 94305
mddake@stanford.edu
Dr. John L. Hennessy
Office of the President
Building 10
Stanford University
Stanford, CA 94305-2061
hennessy@stanford.edu
Dr. John Etchemendy
Office of the Provost
Building 10
Stanford University
Stanford, CA 94305-2061
etch@stanford.edu
Martha H. Marsh
President and CEO
Stanford Hospital and Clinics
300 Pasteur Drive
Room H3200 Stanford, CA 94305
Ann Margaret Arvin
Vice Provost and Dean of Research
Building 10, Main Quad
Stanford, California 94305-2061
aarvin@stanford.edu
Harry B Greenberg
Senior Associate Dean for Research
Dean's Office, School of Medicine
Alway Bldg., M121
300 Pasteur Dr.
Stanford, California 94305-5119
harry.greenberg@stanford.edu
Paul Costello
Executive Director, Communication and Public Affairs
School of Medicine
555 Middlefield Road Bldg. 110
Menlo Park, California 94025
paul.costello@stanford.edu
Jonathan Rabinovitz
News Editor, editor of Medical Center Report
555 Middlefield Road
Menlo Park, CA 94025
jrabin@stanford.edu
Rosanne Spector
Stanford Medicine Editor
555 Middlefield Road
Menlo Park, CA 94025
Stanford Medicine Editor
manishma@stanford.edu
If you are going to discuss your donation plans, add
Laurel Price Jones
Associate Vice President for Medical Development and Alumni Affairs
2700 Sand Hill Road
Menlo Park, California 94025
lpj@stanford.edu